| 1 |
34375677 | Efficacy evaluation of PCSK9 monoclonal antibody (Evolocumab) in combination with Rosuvastatin and Ezetimibe on cholesterol levels in patients with coronary heart disease (CHD): A retrospective analysis from a single center in China. | 2022 Apr |
2 |
| 2 |
35466160 | Advancements in the Treatment of Homozygous Familial Hypercholesterolemia. | 2022 Apr 24 |
1 |
| 3 |
33738013 | Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis. | 2021 Apr |
4 |
| 4 |
33941059 | Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol. | 2021 Mar 5 |
1 |
| 5 |
32072178 | Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study. | 2020 Oct 21 |
2 |
| 6 |
32202541 | [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts]. | 2020 Apr |
2 |
| 7 |
31061366 | Efficacy and Safety of Ezetimibe in Combination with Atorvastatin for Acute Coronary Syndrome Patients Accompanied with Type 2 Diabetes: A Single-Center, Non-randomized Cohort Study. | 2019 |
1 |
| 8 |
31434507 | Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial. | 2019 Sep 17 |
5 |
| 9 |
28444187 | Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting. | 2018 Jan 1 |
1 |
| 10 |
29038147 | Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe. | 2018 Feb |
1 |
| 11 |
29169939 | The association between hypercholesterolemia and sitosterolemia, and report of a sitosterolemia kindred. | 2018 Jan - Feb |
1 |
| 12 |
29233637 | Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation. | 2018 Jan - Feb |
1 |
| 13 |
29396832 | Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2018 Mar |
2 |
| 14 |
29805487 | Effectiveness and safety of combinational therapy compared with intensified statin monotherapy in patients with coronary heart disease. | 2018 Jun |
1 |
| 15 |
29857919 | Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia. | 2018 Jun |
1 |
| 16 |
29910030 | Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. | 2018 Oct |
1 |
| 17 |
30023003 | Adding ezetimibe to statin therapy: latest evidence and clinical implications. | 2018 |
6 |
| 18 |
30326894 | Comparing the combination therapy of ezetimibe and atorvastatin with atorvastatin monotherapy for regulating blood lipids: a systematic review and meta-analyse. | 2018 Oct 17 |
1 |
| 19 |
30470229 | Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers. | 2018 Nov 23 |
2 |
| 20 |
30480766 | Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events. | 2018 Nov 19 |
2 |
| 21 |
27531965 | A study in high-risk, maximally pretreated patients to determine the potential use of PCSK9 inhibitors at various thresholds of total and LDL cholesterol levels. | 2017 Apr |
1 |
| 22 |
28291866 | Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial. | 2017 May 1 |
1 |
| 23 |
28430910 | Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial. | 2017 Aug 1 |
1 |
| 24 |
28496547 | Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia. | 2017 Jun |
5 |
| 25 |
28506389 | Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience. | 2017 May - Jun |
1 |
| 26 |
28599257 | Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. | 2017 Aug |
1 |
| 27 |
28639183 | Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Its Inhibitors: a Review of Physiology, Biology, and Clinical Data. | 2017 Aug |
2 |
| 28 |
28647412 | Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial. | 2017 Jul - Aug |
3 |
| 29 |
28711708 | Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients. | 2017 Aug |
1 |
| 30 |
28750477 | Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care. | 2017 Aug |
1 |
| 31 |
28750828 | Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II). | 2017 Sep 15 |
1 |
| 32 |
29172973 | Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial Hypercholesterolemia. | 2017 Dec |
3 |
| 33 |
29201198 | Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction. | 2017 Nov |
2 |
| 34 |
29255347 | Pharmacokinetic and pharmacodynamic interaction between ezetimibe and rosuvastatin in healthy male subjects. | 2017 |
1 |
| 35 |
26510755 | Effect of Statin Therapy in 4-Year-Old Dichorionic Diamniotic Twins with Familial Hypercholesterolemia Showing Multiple Xanthomas. | 2016 |
1 |
| 36 |
26638010 | Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. | 2016 Jan |
1 |
| 37 |
26792014 | The Role of Ezetimibe in the Treatment of Cardiovascular Disease. | 2016 Feb |
2 |
| 38 |
26916323 | [Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack]. | 2016 Mar 1 |
3 |
| 39 |
27039291 | Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. | 2016 Apr 19 |
3 |
| 40 |
27620638 | Novel Therapies for Familial Hypercholesterolemia. | 2016 Nov |
1 |
| 41 |
27739167 | Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date. | 2016 Nov |
1 |
| 42 |
25626487 | Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom. | 2015 Apr 1 |
3 |
| 43 |
25714444 | The usefulness of a cholesterol absorption inhibitor in Japanese type 2 diabetes patients with dyslipidemia. | 2015 Jun |
3 |
| 44 |
25902885 | Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease. | 2015 May 13 |
1 |
| 45 |
26089847 | Attainment of multifactorial treatment targets among the elderly in a lipid clinic. | 2015 May |
1 |
| 46 |
26134926 | Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect? | 2015 |
2 |
| 47 |
26169307 | Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. | 2015 Jul |
1 |
| 48 |
26385394 | Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future. | 2015 Nov |
2 |
| 49 |
26638446 | [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?]. | 2015 Sep |
2 |
| 50 |
24259646 | Biologics for the treatment of dyslipidemias: a look beyond conventional therapy. | 2014 Feb |
1 |